Financhill
Back

Mackenzie Core Plus Cdn FxdETF Vs. Mirum Pharmaceuticals Industry Stock Comparison

Sell
45

MKB.TO
Mackenzie Core Plus Cdn FxdETF

Last Price:
19.49
Seasonality Move:
0.53%
Sell
40

MIRM
Mirum Pharmaceuticals

Last Price:
39.35
Seasonality Move:
5.99%
Sell
45
Mackenzie Core Plus Cdn FxdETF (MKB.TO) is a Sell

Is Mackenzie Core Plus Cdn FxdETF a Buy, Sell or Hold?

  • The current Mackenzie Core Plus Cdn FxdETF [MKB.TO] share price is $19.48. The Score for MKB.TO is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • MKB.TO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Mirum Pharmaceuticals (MIRM) is a Sell

Is Mirum Pharmaceuticals a Buy, Sell or Hold?

  • The current Mirum Pharmaceuticals [MIRM] share price is $37.93. The Score for MIRM is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • MIRM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MKB.TO Stock Price Chart

What is Mackenzie Core Plus Cdn FxdETF's stock price today?

  • The Mackenzie Core Plus Cdn FxdETF share price today is $19.48
    The current trend is moderately bullish and MKB.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.

MIRM Stock Price Chart

What is Mirum Pharmaceuticals's stock price today?

  • The Mirum Pharmaceuticals share price today is $37.93
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MIRM is experiencing slight buying pressure.

MKB.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.08 Buy
Relative Strength Index (14 RSI): 61.19 Buy
Chaikin Money Flow: -13289 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

MIRM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 36.81 Sell
Chaikin Money Flow: -512602 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

MKB.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.49 Sell
20-day SMA: 19.4 Buy
50-day SMA: 19.22 Buy
200-day SMA: 18.87 Buy
8-day EMA: 19.48 Sell
20-day EMA: 19.41 Buy
50-day EMA: 19.25 Buy
200-day EMA: 18.9 Buy

MIRM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.68 Sell
20-day SMA: 41.55 Sell
50-day SMA: 40.65 Sell
200-day SMA: 31.03 Buy
8-day EMA: 40.34 Sell
20-day EMA: 40.95 Sell
50-day EMA: 39.41 Sell
200-day EMA: 32.8 Buy

Mackenzie Core Plus Cdn FxdETF Earnings Growth & MKB.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Mirum Pharmaceuticals Earnings Growth & MIRM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.38 per share, an increase next quarter of $0.30 per share, an increase this year of $1.79 per share, and an increase next year of $0.88 per share.

Mackenzie Core Plus Cdn FxdETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Mirum Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):